-
Barclays recently drew regulatory scrutiny after a complaint to the Bank of England's Prudential Regulation Authority about how traders classified derivatives tied to illiquid private credit loans, and it also appointed Sonali Sharma as managing director and head of legal in India with responsibility for regulatory and government relations.
-
The combination of a fresh legal leadership hire and a probe into private credit risk treatment places Barclays' control framework, compliance culture and operational risk management in clear focus for investors tracking its core banking franchises.
-
We will now examine how Barclays' investment narrative is shaped by the Bank of England's probe into its private credit derivative risk treatment.
First, review how Barclays responds to this regulatory spotlight. Then, take a broader view with a curated set of banks and financials that currently screen as 4 resilient stocks with low risk scores .
Barclays Investment Narrative Recap
To own Barclays, you need to be comfortable with a large, diversified lender that is trying to squeeze more profit from technology, structural hedge income and a tilt toward UK retail, corporate and US consumer banking. The near term swing factor is how cleanly it executes that mix shift while keeping fraud losses, bad loans at 2% and legal costs contained. The current Bank of England probe into private credit derivatives goes straight to that question but does not on its own change the long term thesis.
The biggest operational risk right now is that complex credit exposures, higher risk funding at 64% of liabilities and legal disputes around shadow banks translate into persistently higher impairments and compliance spend. That would restrict capital generation and limit flexibility on buybacks or growth projects. In the short term, investors are watching for any capital impact or tighter trading controls from the probe that could drag on the Investment Bank, while digital, AI and US consumer initiatives keep progressing.
The most relevant recent development is Barclays appointing Sonali Sharma as managing director and head of legal in India, with responsibility that includes regulatory and government relations. For a bank under review by the Prudential Regulation Authority over private credit risk treatment, experienced legal leadership in a major operating hub can matter for how rules are interpreted, documented and escalated across the group. Her background across Bank of America, Standard Chartered and Avendus signals deep exposure to complex wholesale and local regulatory regimes.
For you as a shareholder, the link is simple. The constructive case depends on Barclays tightening risk controls in complex products, improving net margins through cost work and technology, and keeping structural hedge income and RoTE progress intact. Missteps on documentation, model use or regulator engagement would pull against those potential catalysts through higher capital charges or constraints on certain types of trading. Effective legal oversight is not a guarantee of better outcomes, but it is a key part of the execution story you may wish to track alongside earnings, impairments and funding mix.
Barclays Earnings Path Behind the Regulatory Noise
Barclays' narrative projects £34.6 billion revenue and £9.2 billion earnings by 2029. This assumes 7.1% yearly revenue growth and an earnings increase of about £2.4 billion from £6.8 billion today.
Uncover how Barclays' fair value indicates a 37% potential upside to its current price that could narrow quickly if sentiment turns in favor of Barclays.
Exploring Other Perspectives
Some of the most optimistic Barclays analysts put far more weight on cost cuts than on regulatory noise. Before this probe and the Sonali Sharma appointment, the bullish camp was modelling revenue of about £36.5b and earnings near £10.8b by 2029. You can treat that as one possible path and compare it with more cautious views.
Explore 6 other Barclays fair value estimates , including one that suggests up to 121% upside from the current price!
Reach Your Own Conclusion
Don't just follow the ticker; dig into the data and build a conviction that's truly your own.
-
A great starting point for your Barclays research is our analysis highlighting 5 key rewards and 4 important warning signs that could impact your investment decision.
-
See our latest analysis for Barclays. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Barclays' overall financial health at a glance.
Looking For More Investment Ideas Beyond Barclays?
Once you have a view on Barclays, it can help to compare that thesis with other opportunities that share similar qualities or offer something completely different on risk, income or balance sheet strength.
-
For investors who want resilience first, review companies that currently show a 4 resilient stocks with low risk scores profile and see how their risk scores compare with Barclays.
-
If income is your priority, check out businesses in the 5 dividend fortresses and see which ones offer yields that match your return targets.
-
When you are hunting for quality at a reasonable price, scan the 7 high quality undervalued stocks and line those candidates up against your view on Barclays.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BARC.L .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
